Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 708

1.

Comparison of the Efficacy of Gefitinib in Patients with Non-Small Cell Lung Cancer according to the Type of Epidermal Growth Factor Receptor Mutation.

Igawa S, Kasajima M, Ishihara M, Kimura M, Hiyoshi Y, Asakuma M, Otani S, Katono K, Sasaki J, Masuda N.

Oncology. 2014 Jul 15;87(4):215-223. [Epub ahead of print]

PMID:
25034225
[PubMed - as supplied by publisher]
2.

Observational Study of Axilla Treatment for Breast Cancer Patients with 1-3 Positive Micrometastases or Macrometastases in Sentinel Lymph Nodes.

Oba MS, Imoto S, Toh U, Wada N, Kawada M, Kitada M, Masuda N, Taguchi T, Minami S, Jinno H, Sakamoto J, Morita S; on behalf of the Japanese Society for Sentinel Node Navigation Surgery.

Jpn J Clin Oncol. 2014 Jul 16. pii: hyu090. [Epub ahead of print]

PMID:
25030214
[PubMed - as supplied by publisher]
3.

Phase II Study of S-1 in Combination with Trastuzumab for HER2-positive Metastatic Breast Cancer.

Takashima T, Nakayama T, Yoshidome K, Kawajiri H, Kamigaki S, Tsurutani J, Arai T, Ito T, Komoike Y, Doi T, Masuda N, Miyauchi K, Miyoshi Y, Sakamoto J, Morita S, Taguchi T.

Anticancer Res. 2014 Jul;34(7):3583-8.

PMID:
24982373
[PubMed - in process]
4.

The present state and perception of young women with breast cancer towards breast reconstructive surgery.

Nozawa K, Ichimura M, Oshima A, Tokunaga E, Masuda N, Kitano A, Fukuuchi A, Shinji O.

Int J Clin Oncol. 2014 Jul 1. [Epub ahead of print]

PMID:
24975459
[PubMed - as supplied by publisher]
5.

A phase II study of metronomic paclitaxel/cyclophosphamide/capecitabine followed by 5-fluorouracil/epirubicin/cyclophosphamide as preoperative chemotherapy for triple-negative or low hormone receptor expressing/HER2-negative primary breast cancer.

Masuda N, Higaki K, Takano T, Matsunami N, Morimoto T, Ohtani S, Mizutani M, Miyamoto T, Kuroi K, Ohno S, Morita S, Toi M.

Cancer Chemother Pharmacol. 2014 Aug;74(2):229-38. doi: 10.1007/s00280-014-2492-y. Epub 2014 May 29.

PMID:
24871032
[PubMed - in process]
6.

Novel benzimidazole derivatives as phosphodiesterase 10A (PDE10A) inhibitors with improved metabolic stability.

Chino A, Masuda N, Amano Y, Honbou K, Mihara T, Yamazaki M, Tomishima M.

Bioorg Med Chem. 2014 Jul 1;22(13):3515-26. doi: 10.1016/j.bmc.2014.04.023. Epub 2014 Apr 20.

PMID:
24837154
[PubMed - in process]
7.

Network-dependent modulation of brain activity during sleep.

Watanabe T, Kan S, Koike T, Misaki M, Konishi S, Miyauchi S, Miyahsita Y, Masuda N.

Neuroimage. 2014 Sep;98:1-10. doi: 10.1016/j.neuroimage.2014.04.079. Epub 2014 May 9.

PMID:
24814208
[PubMed - in process]
8.

Circulating tumor cells as a prognostic factor in patients with small cell lung cancer.

Igawa S, Gohda K, Fukui T, Ryuge S, Otani S, Masago A, Sato J, Murakami K, Maki S, Katono K, Takakura A, Sasaki J, Satoh Y, Masuda N.

Oncol Lett. 2014 May;7(5):1469-1473. Epub 2014 Mar 5.

PMID:
24765158
[PubMed]
Free PMC Article
9.

Acquisition of useful sero-diagnostic autoantibodies using the same patients'sera and tumor tissues.

Kobayashi M, Nagashio R, Ryuge S, Murakami Y, Yanagita K, Nakashima H, Matsumoto T, Jiang SX, Saegusa M, Satoh Y, Masuda N, Sato Y.

Biomed Res. 2014;35(2):133-43.

PMID:
24759181
[PubMed - in process]
Free Article
10.

[Observational study on urinary status following HoLEP].

Kono Y, Matsumoto K, Masuda N, Shiraishi Y, Negoro H, Utsunomiya N, Tsunemori H, Okubo K, Okada T, Segawa T, Muguruma K, Kawakita M.

Hinyokika Kiyo. 2014 Feb;60(2):57-60. Japanese.

PMID:
24755814
[PubMed - indexed for MEDLINE]
11.

[Effect of oral dexamethasone given 24 hours previously on docetaxel-induced edema: a retrospective study].

Kato A, Masuda N, Makihara K, Ueno H, Hirohata K, Yamauchi K, Yasojima H, Mizutani M, Yamamura J, Komori K.

Gan To Kagaku Ryoho. 2014 Feb;41(2):211-4. Japanese.

PMID:
24743199
[PubMed - indexed for MEDLINE]
12.

Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial.

André F, O'Regan R, Ozguroglu M, Toi M, Xu B, Jerusalem G, Masuda N, Wilks S, Arena F, Isaacs C, Yap YS, Papai Z, Lang I, Armstrong A, Lerzo G, White M, Shen K, Litton J, Chen D, Zhang Y, Ali S, Taran T, Gianni L.

Lancet Oncol. 2014 May;15(6):580-91. doi: 10.1016/S1470-2045(14)70138-X. Epub 2014 Apr 14.

PMID:
24742739
[PubMed - indexed for MEDLINE]
13.

Randomized phase II study of weekly paclitaxel with and without carboplatin followed by cyclophosphamide/epirubicin/5-fluorouracil as neoadjuvant chemotherapy for stage II/IIIA breast cancer without HER2 overexpression.

Ando M, Yamauchi H, Aogi K, Shimizu S, Iwata H, Masuda N, Yamamoto N, Inoue K, Ohono S, Kuroi K, Hamano T, Sukigara T, Fujiwara Y.

Breast Cancer Res Treat. 2014 Jun;145(2):401-9. doi: 10.1007/s10549-014-2947-1. Epub 2014 Apr 12.

PMID:
24728578
[PubMed - in process]
14.

Aminophylline increases respiratory muscle activity during hypercapnia in humans.

Yokoba M, Ichikawa T, Takakura A, Ishii N, Kurosaki Y, Yamada Y, Tsukushi T, Masuda N, Easton PA, Katagiri M.

Pulm Pharmacol Ther. 2014 Apr 8. pii: S1094-5539(14)00038-8. doi: 10.1016/j.pupt.2014.03.006. [Epub ahead of print]

PMID:
24721495
[PubMed - as supplied by publisher]
15.

Survival of HER2-positive primary breast cancer patients treated by neoadjuvant chemotherapy plus trastuzumab: a multicenter retrospective observational study (JBCRG-C03 study).

Takada M, Ishiguro H, Nagai S, Ohtani S, Kawabata H, Yanagita Y, Hozumi Y, Shimizu C, Takao S, Sato N, Kosaka Y, Sagara Y, Iwata H, Ohno S, Kuroi K, Masuda N, Yamashiro H, Sugimoto M, Kondo M, Naito Y, Sasano H, Inamoto T, Morita S, Toi M.

Breast Cancer Res Treat. 2014 May;145(1):143-53. doi: 10.1007/s10549-014-2907-9. Epub 2014 Mar 30.

PMID:
24682674
[PubMed - in process]
16.

Primary chest wall abscess mimicking a breast tumor that occurred after blunt chest trauma: a case report.

Yamaoka Y, Yamamura J, Masuda N, Yasojima H, Mizutani M, Nakamori S, Kanazawa T, Kuriyama K, Mano M, Sekimoto M.

Case Rep Med. 2014;2014:620876. doi: 10.1155/2014/620876. Epub 2014 Feb 9.

PMID:
24660001
[PubMed]
Free PMC Article
17.

Plasma pentraxin 3 is a more potent predictor of endothelial dysfunction than high-sensitive C-reactive protein.

Yasunaga T, Ikeda S, Koga S, Nakata T, Yoshida T, Masuda N, Kohno S, Maemura K.

Int Heart J. 2014;55(2):160-4. Epub 2014 Mar 14.

PMID:
24632958
[PubMed - indexed for MEDLINE]
Free Article
18.

Energy landscapes of resting-state brain networks.

Watanabe T, Hirose S, Wada H, Imai Y, Machida T, Shirouzu I, Konishi S, Miyashita Y, Masuda N.

Front Neuroinform. 2014 Feb 25;8:12. doi: 10.3389/fninf.2014.00012. eCollection 2014.

PMID:
24611044
[PubMed]
Free PMC Article
19.

Evolutionary dynamics in finite populations with zealots.

Nakajima Y, Masuda N.

J Math Biol. 2014 Mar 8. [Epub ahead of print]

PMID:
24610380
[PubMed - as supplied by publisher]
20.

[Effect of change to flutamide for prostate cancer patient who developed breast pain during bicalutamide treatment (BIP-F study)].

Kitamura Y, Okuno H, Sakura Y, Manabe Y, Masuda N, Ito H, Mishina M, Taoka R, Terai A, Sugimoto M, Kakehi Y.

Hinyokika Kiyo. 2014 Jan;60(1):17-23. Japanese.

PMID:
24594768
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk